Interview with Derek Williams, Vice President and General Manager, Vifor Pharma…
You joined Vifor Pharma to establish a new structure in the UK. It is quite difficult to set up a new enterprise—what have been the main challenges for yourself and…
Address: Flughofstrasse 61, CH-8152 Glattbrugg,Germany
Tel: +41 58 851 80 00
Web: http://www.viforpharma.com/en/
Vifor Pharma is a fully integrated specialty pharma company within the Galenica Group. It unites all companies in the Pharma business sector of Galenica under one single umbrella organisation that researches, develops, produces and markets specific pharmaceutical products throughout the world.It is based on two main pillars: the business units Rx (prescription products) and Consumer Healthcare (OTC products). The operational basis of Vifor Pharma are lean and agile organisational structures. Vifor Pharma enjoys an increasing global presence. While the manufacture of all products is located in Switzerland and in the UK, the commercialisation is taken over by a wide network of affiliates and distributors all over the world.The business unit Vifor Pharma Consumer Healthcare manufactures and markets non-prescription products (OTC products) developed within Vifor Pharma or produced or sold under licence. Vifor Pharma plays a leading role in the area of non-prescription medicines, both in Switzerland and in selected countries of export. The focus of Vifor Pharma Consumer Health is on the development of own structures in key markets in Europe and on the continual optimisation of the product range through own developments and through the acquisition of products, licences and companies.
You joined Vifor Pharma to establish a new structure in the UK. It is quite difficult to set up a new enterprise—what have been the main challenges for yourself and…
The DKFZ – German Cancer Research Center – is Germany’s largest cancer research institute with an international recognition recently coroneted with the Nobel Prize to Mr Harald zur Hausen for…
2007 was a turning point for the German Pharmaceutical Industry as the Healthcare Reform from 2007 took place and the Special SHI enhancement Act entered into force. Two years down…
What role does the German Pharmaceutical Industry Association (BPI) play for the German pharmaceutical industry? BPI is the oldest industry association of the German pharmaceutical industry, dating back to 1951.…
Next year Baxter will accomplish its 50th anniversary in Germany. In the context of its celebration, what would you highlight as the main achievements of the company especially since you…
In the last twenty years, Germany has experienced nearly twenty health care reforms. In your opinion, what have been the main reasons for so many changes? The main reason behind…
Astellas has been present in the German market for almost two decades through Yamanouchi and Fujisawa. But since 2005 it gained a new identity thanks to the merger of the…
Cytonet is today Germany’s largest cell therapy enterprise. However, it went through many transformations since its spin-off from Roche Diagnostics in 2000. Could you briefly introduce the company to our…
The German Pharmaceutical Industry is not only known for its cutting-edge R&D and production base but also for having a high penetration of generics. In your opinion, what role do…
You have a wide experience in the pharmaceutical industry having worked for companies such as Amgen and Servier. What attracted you to Basilea? When I first considered moving to Basilea…
When we met Dr. Aleiotti in Italy, he said how important was Menarini´s acquisition of Berlin Chemie in the 1990s for the internationalization of the company in Eastern Europe and…
With a wide experience in other international pharmaceutical companies, what attracted you to come to Bausch&Lomb, the ophthalmology pharma company? Bausch&Lomb offered me a unique set of challenges and possibilities…
Gilead was founded in 1987 and only four years later it established itself in the German market. Since then the company has become internationally known for breakthroughs that resulted in…
See our Cookie Privacy Policy Here
